Company intelligence / Profile preview

Somatus

McLean, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Somatus delivers value-based, specialist-led integrated care for kidney and heart disease using proprietary AI, predictive analytics, and whole-person care coordination; clinical outcomes include significantly improved blood pressure control, higher home dialysis initiation, reduced mortality, and higher kidney transplant rates versus national benchmarks

Therapeutic areas: NephrologyCardiovascularEndocrinology
Modalities: Non-pharmacological therapyDeviceData analytics platform
Industry: Non-Academic Healthcare

Partnerships

100+ nephrology practices5,500+ providers in value-based care arrangementsPartnerships with major health plans, health systems, specialty providers, and self-insured employers

Beyond the preview

Go deeper on Somatus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somatus.

Explore the full profile